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The 5’-3’ exoribonuclease Rat1 promotes termination of RNA polymerase II 
(RNAPII) on protein-coding genes, but its underlying molecular mechanism is still 
poorly understood. Using in vitro transcription termination assay, I have found that 
RNAPII is prone to terminate more effectively by Rat1/Rai1 when its catalytic site is 
disrupted due to NTP misincorporation, proposing that paused RNAPII often found 
in vivo near termination sites might adopt similar configuration for Rat1 to trigger 
termination. Intriguingly, Rat1 does not terminate E. coli RNAP, implying that 
specific interaction between Rat1 and RNAPII may also contribute to termination. 
Furthermore, the efficiency of termination increases as the RNA transcript being 
degraded by Rat1 gets longer. It suggests that Rat1 may generate a driving force for 




catch up the polymerase. These results indicate that multiple mechanistic features 
contribute to Rat1-mediated termination of RNAPII.  
Keywords: Transcription, RNAPII, Termination, 5´-3´ exoribonuclease, 
Rat1/Rai1, Rtt103 
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1.1. RNA Polymerase II and transcription process 
In eukaryotes, there are three classes of RNA polymerases: RNAPI transcribes rRNAs, 
RNAPII transcribes mRNAs and majority of non-coding RNAs (sn/snoRNA, miRNA, 
CUTs, SUTs), and RNAPIII transcribes 5S rRNA and tRNAs. The RNA polymerases 
are multisubunit proteins and structurally well conserved each other (Fig.1.1) (1). 
RNAPII consists of ten-subunit core and peripheral heterodimer of subunits Rpb4 
and Rpb7 which are dissociable from core subunits (Table 1.1) (1). RNAPII has four 
different mobile elements: core, clamp, shelf, and jaw lobe. The cleft lies in the center 
of the enzyme where incoming DNA penetrates into the active site (2) (Fig 1.2). The 
structural study reveals that double-stranded DNA enters the main cleft but cannot 
proceeds further, rather RNAPII unwinds DNA and single-stranded DNA enters deep 
into the cleft and reaches active site. It shows 8-9 base pairs of DNA-RNA hybrid lies 
in the active site and 3’ end of RNA is positioned above a pore liked to funnel, 
implying the backtracking of RNAPII for proofreading of RNA extension (3) .  
The core RNAPII has two different states: pre-initiation complex (PIC) and open-
complex (OC). PIC is analogous to the bacterial closed complex and with all general 
transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH) bind to the 
promoter to initiate transcription at the start site (Fig1.3) (4). Recognition of the 
promoter elements by transcription machinery is essential for recruitment of general 
transcription factors and assembly of PIC. TFIIB (TBP) binds minor groove of an 
8bp-TATA element and serve as a platform for binding other components of PIC.  
 After PIC is assembled, it is poised before the conversion into transcriptionally 
active state and moves on to the next step using ATP-dependent helicase activity (5). 
ATP-dependent helicase (XBP), a subunit of TFIIH, binds to the downstream DNA 




structure of XPB-DNA interaction is now solved yet, the detailed underlying 
mechanism is not elucidated.  
Open-complex escaped from promoter starts to elongate mRNA moving along the 
DNA template. Elongation is achieved by repetitive cycles of NTP additions. The 
Elongation-complex (EC) consists of short duplex DNA and single strand RNA 






















Table 1.1. RNA polymerase subunits  
RNA polymerase RNAP I RNAP II RNAP III 































































Figure 1.1.  Structurally conserved ten core subunits of eukaryotic RNA polymerases 
(adapted from Cramer et al, 2008) (1) 
Structures of multisubunit RNAPI, II and III composed of 14, 12 and 17 subunits in yeast, 
respectively. There are ten conserved core subunits and additional subunits located on the 
periphery. (a) RNAPI hybrid structure. (b) Ribbon model of complete RNAPII crystal 
structure. (c) RNAPIII EM structure. (d) Rpb4/7 subcomplex structures: A14/43 (left), 












Figure 1.2. Structure of RNAPII elongation complex (adapted from Hahn, 2004) (2) 
(a)  Top view of RNAPII with the DNA template strand (blue), nontemplate strand (green), 














Figure 1.3. Cycle of transcription initiation and reinitiation for RNAPII (adapted from 
Hahn, 2004) (2) 
RNAPII and transcription general factors are recruited to promoter regions. Once 
preinitiation complex (PIC) is assembled, it undergoes transition state before conversion 
into open complex. Using ATP, unstable open complex is formed and escapes from 
promoter region to initiate transcription. General transcription factors remaining behind at 
the promoter after initiation keep scaffold complex and bind next RNAPII to reinitiate 














An EM analysis reports that the transition between open-complex and PIC depends 
on the movement of jaw domain of RNAPII (6).  
 
1.2. Importance of transcription termination study  
The definition of transcription termination is that RNAPII is dissociated from DNA 
template after the elongating RNAPII recognizes termination signal such as poly(A) 
site.   
Accurate transcription termination is crucial because early or late termination may 
disrupt normal gene regulation and produce abnormal RNAs, which may be harmful 
to cellular fitness. Recent studies show that when human non-coding RNA 
termination factor senataxin is mutated, severe neurological defects such as recessive 
disorder ataxia with oculomotor apraxia type 2 (AOA2) are observed in mouse and 
human (7). MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and 
stroke-like episodes) patients show mutations occurred within the mtDNA binding 
site of mTERF protein which promotes transcription termination at 16S rRNA/tRNA 
(8). Also, mutations in anti-terminator factor Tat are responsible for postintegration 
latency of Human Immunodeficienty Virus (HIV) (9). These results suggest that fine 
tuning of transcription termination is essential for the life of organisms.  
 
1.3. Two distinct termination pathways: for mRNAs vs non-coding RNAs 
In Saccharomyces cerevisiae, there are at least two distinct pathways for RNAPII 
termination (10). One pathway involves Nrd1/Nab3/Sen1 complex to terminate non-
coding RNA transcription and is independent of cleavage of nascent RNA transcripts 
(11,12). In contrast, the other termination pathway for most protein-coding genes 
requires cleavage of nascent transcripts by cleavage/polyadenylation factors, and 
RNA degradation from the newly formed 5’ phosphorylated end by 5’- 3’ 
exoribonuclease Rat1 which promotes RNAPII termination (13,14) (Fig 1.4.a). Rat1 




cleavage and thereby generating an entry site for 5’-3’ exoribonuclease to trigger 
termination. Supporting this notion, previous study shows that RNA cleavage factors 
(Rna14, Rna15 and Pcf11) but not polyadenylation factors (Pap1, Fip1 and Yth1) are 
required for termination (15).   
When elongating RNAPII recognizes poly(A) signal,  it slows down and 
polyadenylation and cleavage factors (CPF, CF1A/CF1B complex and Pap1) are 
recruited to the polymerase.  After cleavage and polyadenylation of premature RNA, 
it is exported to cytoplasm to be translated. Then, the remaining 5’ phosphorylated 
nascent RNA is removed not to create defective mRNAs by Rat1 which rapidly 
degrades RNA from 5’-3’ direction catching up the slow-moving RNAPII. Once Rat1 
approaches the surface of RNAPII, it somehow docks on polymerase and dissociates 
it from the DNA template. The detailed mechanism about how Rat1 dissociates 
RNAPII is still uncovered (Fig 1.4.b)(13). 
 
1.4. The role of Rat1 and characterization of its interacting partners 
The yeast Rat1 is an essential nuclear protein and evolutionally well conserved from 
yeast to human (Xrn2 in human) (14,16,17). Rat1 is 116kDa-dize and recognizes 
monophosphate of single-strand RNA and processively degrades it. Rat1’s human 
homologue Xrn2 is also nuclear exoribonuclease and specifically localizes in 
nucleolar. It plays a role in not only termination of mRNA but also both maturation 
of rRNA and degradation of various discarded pre-rRNA species (18).  
Rat1’s cytoplasmic counterpart Xrn1 in yeast is also a processive 5’-3’ 
exoribonuclease. Xrn1 regulates RNA turnover by degrading wide range of 
cytoplasmic RNAs, including noncoding RNAs and Nonsense-Mediate Decay (NMD) 
substrates. Yeast Xrn1 especially degrades long non-coding RNAs (lncRNAs), called 
Xrn1-senstivie unstable transcripts (XUTs) (19). Interestingly, a study shows that 
engineered Xrn1 having nucleus localizing signal (NLS) can enter nucleus and 




localized to cytoplasm instead of nucleus. This suggests that Rat1 and its counterpart 
Xrn1 are functionally interchangeable and its localizations are tightly linked to its 
function in transcription termination (20).  
Rat1 acts as a complex with Rai1 that confers stability on Rat1 and helps to target 
5’ monophosphate RNA by its pyrophosphohydrolase activity (21) (Fig 1.5). Rai1 in 
yeast is homologous to Dom3Z in human and Dxo1 in Kluyveromyces lactis. 
Interestingly, unlike Rai1, hDom3Z and Dxo1 show decapping and 5’-3’ 
exoribonuclease activities. Especially, hDom3Z preferentially degrades defectively 
capped pre-mRNAs in vivo (22,23). Generally, 5’-end capping was believed to 
proceed to completion and does not require quality-control mechanisms to maintain 
the fidelity of the 5’ end cap. However, recent structural studies clearly show that 
termination factor is involved in quality control function of incomplete 5’end capping 
of mRNA, thereby providing possible link between 5’end RNA processing and 
transcription termination.  
Not only possible role of Rai1 homologue at 5’end of gene but also localization 
of Rat1 at the region implies that Rat1-dependent transcription termination could 
occur upstream the polyadenylation sites (13). Supporting this, rat1-dependent 
termination is observed in the capping-deficient ceg1-63 strain (24) and, in 
mammals, Xrn2 contributes to the maturation of 5’end of rRNAs by degrading 
improperly processed intermediates (18). All of these results suggest that Rat1-
mediated termination could be linked to not only properly processed mRNA but also 
improperly processed pre-mature RNAs in yeast and mammals. 
Another interacting protein Rtt103 has a CID (RNAPII C-terminal domain-
interacting domain) which might facilitate the access of Rat1 to RNAPII via 
interaction with Ser2-phosphorylated CTD (13,25). Numerous studies, over the past 
decades, have reported the tight relationships between CTD phosphorylation and 
transcription process (Fig 1.6). The largest subunit of RNAPII (Rpb1) has C-terminal 






Figure 1.4. Decision tree of termination pathway and Torpedo model (13)  
(a) Two distinct termination pathways for mRNAs and non-coding RNAs. mRNA genes are 
terminated cleavage dependently whereas non-coding RNAs are terminated cleavage 
independently. Rat1/Rai1/Rtt103 plays a role in cleavage-dependent pathway and 
Nrd1/Nab3/Sen1 does in cleavage-independent pathways.  (b) Rat1 acts like a torpedo 
catching up slow-moving RNAPII degrading 5’ phosphorylated nascent RNA, and dislodge 






number of repeats varies from organism to organism: 26 (all consensus) repeats and 
52 (21 consensus and 31 non-consensus) repeats of YSPTSPS in yeast and mammals. 
Serine2, Serine 5 and Serine 7 are the major sites of CTD phsohporylation. Generally, 
towards 3’ end of gene body, Ser5P level drops and Ser2P level increases, and 
consequently recruitment of termination and RNA processing factors are increased, 
too. Ser2P-binding protein Rtt103 is co-purified with termination complex Rat1/Rai1 
through TAP purification (13). Rtt103 interacts with another CID-harboring 
polyadenylation factor Pcf11 and their cooperative binding to CTD repeats is 
facilitated when the Ser2P level is the highest near at 3’ end of gene. This Rtt103-
Pcf11 interaction provides another level of tight regulation for Rat1-mediated 
















Figure 1.5. Structure of Rat/Rai1 complex in S.pombe (adapted from Xiang et al, 2009) 
(21).  
Crystal structure of S.pombe Rat1/Rai1 complex at 2.2Å resolution. Solved Rat1 structure 
contains residues from 1-885 amino acids, missing the last 106 residues that does not 
affect cell viability. Rai1 is solved as full-length structure. Active site of Rat1 is indicated 
with the red star and a bound divalent cation in the active site of Rat1 is shown as a grey 
sphere. Helix αD domain is called tower domain contributes several conserved residues to 
the active site. Since Xrn1 does not have this domain, the tower domain may be unique 













Figure 1.6. Coupling of transcription and CTD phosphorylation pattern (adapted from 
Egloff et al, 2012) (27).  
The carboxyl-terminal domain (CTD) phosphorylation pattern across yeast genes. The 
average level of Ser2P, Ser5P and Ser7p relative to RNA Polymerase II level detected on 
protein-coding gene during the different steps of the transcription cycle is represented. 
The kinases and phosphatases responsible for establishing these patterns are noted above 














1.5. Previous studies on Rat1/Rai1/Rtt103 complex regarding transcription 
termination in-vitro 
Although there is a big emphasis on the role of Rat1/Rai1/Rtt103 in transcriptional 
termination in vivo, its molecular mechanism of how Rat1 actually dissociates 
RNAPII from DNA template is still unclear.  A recent study adapting scaffold 
transcription elongation complex insisted that Rat1/Rai1 itself is not sufficient to 
terminate RNAPII in vitro It also shows that Rtt103 does not influence the 
exoribonuclease activity of Rat1 arguing that the role of Rtt103 would be dispensable 
for termination in vivo (28).   
However, another in vitro study using promoter-driven elongation complex 
showed that Rat1/Rai1 released stalled RNAPII in the absence of other factors. The 
study agrees with that Rtt103 is not essential for termination but it probably plays a 
redundant role in mediating interaction between Rat1 and RNAPII based on the result 
that Rtt103 restores termination capability in exonucleolytically deficient rat1 D235A 
mutant (25). Thus, what Rat1 requires to promote termination and how it triggers 
RNAPII dissociation still remain obscure. 
 
1.6. Characteristics of RNAPII movements: pausing, backtracking and 
reactivation 
To elucidate the molecular mechanism of Rat1-mediated RNAPII termination, 
studying mechanistic features of RNAPII movement in depth is necessary. Old study 
adapting systematic analysis of transcription elongation complexes reveals that 
irregular DNA footprinting (29), suggesting that RNAP may adopt inchworm 
movement during the elongation. However, the later study shows that irregular 
footprints occur only at certain DNA sites, whereas the majority of DNA positions 
display relatively monotonic movement of RNAP in E.coli (30).  Since then it has 




power-strokes, and thereby frequent pausing, backtracking and transcriptional arrest 
are commonly observed.  
Promoter-proximal pauses are one class of RNAP backtracking events. It is often 
observed in widespread, especially in highly active and regulated genes (31-34). The 
long-lasting pausing is crucial for transcriptional regulation of many genes and in 
RNA processing.  
Besides promoter-proximal pausing, eukaryotic RNAPII often shows sequential 
events of pausing, backtracking and reactivation during elongation. This phenomenon 
is closely related to the transcriptional fidelity, elongation rate control and termination 
mechanisms (Fig 1.7.a). Backtracking of bacterial and eukaryotic RNAPs is triggered 
by weak DNA-RNA hybrid. A recent study solves crystal structure of backtracked 
yeast RNAPII and revealed that arrested polymerase is reactivated by transcription 
factor IIS (TFIIS), which promotes intrinsic RNA cleavage by RNAPII itself (Fig 
1.7.b) (35). In the arrested state, eight nucleotides of backtracked RNA bind backtrack 
site beyond the gating tyrosine in the pore and funnel, trapping the active center trigger 
loop and inhibiting mRNA elongation. In the reactivation state, TFIIS locks the trigger 
loop away from the backtracked RNA, dislodges RNA from the backtrack site and 
complements the active site with a basic and two acidic side chains. This promotes 
intrinsic cleavage of RNAPII and consequently release backtracked RNA creating a 














Figure 1.7. RNAP backtracking scheme and crystal structure of backtracked yeast RNAPII 
(adapted from Cheung et al, 2011 and Nudler, 2012) (35,36).  
(a) Schematic illustration of the ternary elongation complex in active and backtracked 
configurations. The catalytic site (star) looses the 3’-OH end of RNA (red), which is 
extruded through the secondary channel during backtracking. Backtracking is always 
happened with bacterial and eukaryotic RNA polymerases. (b) Backtracking is triggered by 
a weak DNA/RNA hybrid. Side and front views of the arrested RNAPII crystal complex 
structure refined at 3.3 Å resolution with functional elements highlighted. 13-bp of 
downstream DNA, 6-bp hybrid and 9 nucleotides of single-stranded 3’ RNA that is extruded 







1.7. RNAPII pausing induced by NTP misincorporation via template 
misalignment.  
The next question now will be how RNAPII pausing, backtracking and reactivation 
are achieved. One of major factors for RNAPII pausing is NTP-misincorporation via 
template misalignment. As previously described, nucleotides are incorporated into 
active site of polymerases in repetitive cycle. NTP misincorporation leads to slow 
addition of next nucleotides and cleavage of mismatched RNA 3’end by RNA 
polymerase stimulated by Gre factors or TFIIS in bacteria and yeast, respectively. In 
other words, to maintain fidelity, RNA polymerase discriminates nucleotides against 
the wrong one and recognizes and removes mismatched nucleotides through pausing 
and backtracking. During this process, pausing and backtracking is inevitable steps. 
In bacterial EC, a mismatched RNA 3’end is removed by cleavage-stimulatory Gre 
factors (37). In human EC, a mismatched RNA 3’ end nucleotides cause slow addition 
of the next nucleotides and cleaved by TFIIS (38).  
 According to recent works on T7 RNAP, E.coli RNAP and yeast RNAPII, a non-
cognate NTP complementary to the n+1 template DNA base (n+1 NTP) can be 
incorporated through template misalignment, leading to temporary flipping-out of n 
DNA base to extrahelical position. With mismatched nucleotides, RNA transcript can 
be extended after realignment of template DNA (Fig.1.8.). This misalignment 
mechanism seems universal for all DNA-dependent RNAPs including bacterial 
RNAP (39,40).  
The average frequency of NTP misincorporation keeps relatively low for 
eukaryotic RNAPII (~10-5) (41), since Rpb9 and TFIIS stimulate the proofreading 
cleavage activity of RNAPII (42-45). Supporting these results, deletion of RPB9 or 
TFIIS (DST1) gene significantly decreases transcriptional fidelity of yeast RNAPII 
(46). NTP misincorporation would arrest elongation complex and/or induce transient 






Figure 1.8. NTP misincorporation via template misalignment scheme (Kashkina et al, 
2006) (39) 
The template base that is paired with the 3’ end of the RNA in designated as n-1, and the 
template base in the substrate site as n; template bases further downstream are 
designated n+1, n+2 etc. The noncognate substrate complementary to the n+1 base is 
termed the n+1 NTP. In the old misincorporation model (left), the n+1 NTP (CTP) is 
misincorporated opposite the n base, resulting in a mismatch at the 3’ terminus of the 
RNA; this is followed by mismatch extension by correct incorporation of CTP opposite the 
n+1 base. In the new NTP misincorporation via template misalignment model (right), 
misalignment of the T strand allows incorporation of CTP opposite the n+1 base; this is 
followed by realignment of the primer/template and mismatch extension as above. In both 




1.8. Sequence-specific RNAPII pausing 
Not only template misalignment-induced pausing, but also sequence-specific pausing 
occurs in various RNAPs. In case of yeast RNAPII, mismatched T·U wobble base 
pair of DNA/RNA hybrid induces disruption of the catalytic site, resulting in RNAPII 
pausing and backtracking (Fig 1.9) (47).  
In addition, bacterial and T. thermophilus RNAPs also show sequence-specific 
pausing, depending upon the incoming NTP in active sites (48,49). So far, several 
studies report that RNAPII pausing is linked to and stimulates termination by 
Rat1/Xrn2 (50,51), but other than its collaborative feature with a poly (A) signal, how 
the RNAPII pausing contributes to Rat1-mediated termination remains unknown. 
 
1.9. Aims of this study 
Transcription termination is tightly regulated process and numerous factors are 
involved to complete accurate dissociation of RNAPII from the DNA template. In 
Sacchromyces cerevisiae, mRNA transcription termination pathway involves 
Rat1/Rai1/Rtt103 complex, which supports Torpedo model requiring cleavage of 
premature RNA and subsequent degradation of nascent RNA by 5’-3’ 
exoribonuclease. ChIP assays and several in vitro studies reveal that Rat1/Rai1/Rtt103 
is required to promote transcription termination but the detailed molecular mechanism 
is still not fully understood.   
Here, I show using in vitro assays that when NTP misincorporates, RNAPII 
becomes catalytically disrupted and is more efficiently terminated by Rat1/Rai1, 
proposing that pausing of RNAPII often found in vivo near termination site might 
generate a similar configuration to facilitate termination by Rat1/Rai1. Although NTP 
misincorporation also catalytically disrupts E. coli RNAP, Rat1 does not terminate it, 
indicating that specific interaction between Rat1 and RNAPII may be also important 
to induce termination. Additionally, I found that RNAPII termination efficiency 




that Rat1 may generate a driving force to dislodge RNAPII while degrading the 

































Figure 1.9. T·U wobble base pairing and frayed 3’end nucleotides of RNA (Sydow et al, 
2009) (52) 
(a) Structure of the T·U mismatch-containing RNAPII EC. RNAPII is shown from the side as a 
ribbon model in silver, with the bridge helix highlighted in green and a portion omitted for 
clarity. The nucleic acids are shown as stick models using color code. The T·U mismatch is 
shown in orange. (b) Structure of RNAPII EC with frayed 3’ terminal RNA uridine at 3.6 Å 
resolution. The electron density is shown as a blue mesh. The location of the bromine 
atom at position -5 defines the register. (c) Detailed view of frayed site. RNAPII residues 











2. MATERIALS AND METHODS 
2.1. Strains and plasmids construction 
The gene encoding for Saccharomyces cerevisiae Rat1, Rai1, and Rtt103 were cloned 
into pET21b (Novagen) tagged with hexahistidine (6xHis) (gifts from P. Cramer 
Ludwig-Maximilians Universitӓt, Munich, Germany). Human Xrn2 (hXrn2) was 
cloned from cDNA (Harvard DNA Resources) into pET21b tagged with 6xHis. 
Catalytic mutant of rat1 (E203A, D233A, D235A) and rai1 (E221A, D223A) were 
prepared by site-directed mutagenesis. Xrn1 was purchased from NEB (cat# M0338S).  
The rat1 E203A/D233A/D235A (rat1EDD) mutant was generated by PCR 
mutagenesis and cloned into either pET21b or pRS41H. Rtt103 was cloned into 
pRS415 or pRS423 and transformed into a yeast strain (rat1Δ::KanMX/pAJ202-
Rat1/pRS41H-rat1EDD) to test whether extra copies of Rtt103 gene can rescue the 
rat1EDD lethal phenotype when wild-type Rat1 was shuffled out by FOA selection. 
 
2.2. Protein expression and purification 
The recombinant proteins with 6xHis tag of Rat1, Rai1, Rtt103, and TFIIS were over-
expressed in BL21 CodonPlus (DE3) RIL (Stratagene) strain via IPTG induction  
(0.25 mM IPTG) at 25ºC for 6 hr.  
Cells expressing Rat1/Rai1 or Rat1 were lysed by sonication in freezing buffer A 
(50 mM Tris-HCl, pH 7.9 at 24ºC, 150 mM NaCl, 10% glycerol, 10 mM β-ME, 1.8 
µM leupeptin, 5.46 µM pepstatin A, 6.33 mM benzamidine, 37.5 µg bestatin, 3 mM 
PMSF). The lysates were cleared by centrifugation and sequentially applied to Ni-
NTA agarose column (Qiagen), HiTrap Heparin HP affinity column (5 ml, GE 
Healthcare), MonoQ 10/100 GL anion exchange column (GE Healthcare), and 
Superose 6 10/300 GL size-exclusion chromatography. The purified proteins were 
eluted in final buffer (25 mM Tris-HCl, pH 7.9 at 24ºC, 100 mM NaCl, 1 mM MgCl2, 
1 mM DTT, 10% (v/v) glycerol), quick frozen in liquid nitrogen and stored at -80ºC. 




by sonication in freezing buffer B (50 mM Tirs-HCl, pH 7.3 at 24ºC, 150 mM NaCl, 
10% glycerol, 10 mM β-ME, 1.8 µM leupeptin, 5.46 µM pepstatin A, 6.33 mM 
benzamidine, 37.5 µg bestatin, 3 mM PMSF) and the cell lysate was applied to  Ni-
NTA, MonoQ and Superose 6 columns, respectively. The purified protein was eluted 
in final buffer B (25 mM Tris-HCl, pH 6.8 at 24ºC, 125 mM NaCl, 1.25 mM DTT, 
10%(v/v) glycerol). For TFIIS, purification procedure was performed as described 
elsewhere (53). 
Rat1/Rai1/Rtt103 and rat1EDD/Rai1/Rtt103 complex were purified using the 
same procedures but with slightly different buffer conditions. In affinity and ion-
exchange chromatographies, Tris-HCl, pH 7.6 at 24ºC was used. In Superpose 6 size-
exclusion chromatography step, protein complexes were eluted with low-salt storage 
buffer (25 mM Tris-HCl, pH 7.6 at 24 ºC, 80 mM NaCl, 1 mM DTT, 1 mM MgCl2, 
10% (v/v) glycerol). 
For Saccharomyces cerevisiae RNAPII purification, BJ5464 Rpb3 His-Bio strain 
(a gift from P. Cramer) was fermented and purified as described previously (54). 
Rpb4/7 subunit was over-expressed in BL21 CodonPlus (DE3) RIL (Stratagene) 
strain via IPTG induction (0.25 mM IPTG) at 25ºC for 6 hr. It was purified as 
described in elsewhere (55). 
 
2.3. in- vitro transcription termination assay 
Transcription-competent elongation complexes were assembled as previous described 
(28). Template/non-template DNAs and RNAs used to assemble an elongation 
complex (EC) were listed in Supplementary Table 2.1. Briefly, 3 pmol of RNAPII 
was incubated with 2-fold molar excess of DNA/RNA hybrid, 4-fold molar excess of 
5’-biotinylated non-template DNA and 5-fold molar excess of Rbp4/7 to form EC. 
Streptavidin-coated magnetic beads (Dynabeads MyOne streptavidin T1, Invitrogen) 
were pre-blocked O/N  with blocking buffer (50 mM Tris-HCl, pH 8.0 at 25ºC, 150 




BSA, 0.2 mg/ml insulin, 0.1 mg/ml heparin, 0.5 mM DTT) to prevent nonspecific 
binding of ECs. After ECs were bound to beads, 3’-end of RNA was labeled with [α-
32P] UTP by RNAPII.  
For RNA digestion, 6 pmol of Rat1/Rai1 was added to EC and incubated for 1 hr 
at 30ºC in the presence or absence of each single NTP. After the reaction is completed, 
the nuclease and NTP were removed with washing buffer (20 mM Tris-HCl, pH 8.0 
at 30ºC, 500 mM NaCl, 2 mM MgCl2, 1 mM DTT), and EC bound beads were 
resuspended in reaction buffer (20 mM Tris-HCl, pH 8.0 at 30ºC, 150 mM NaCl, 2 
mM MgCl2, 1 mM DTT). Mixture of four NTPs was added to EC and incubated for 
30 min at 28ºC to allow RNAPII elongation. The reactions were stopped and RNA 
samples were analyzed by 7 M Urea-PAGE. The radioactively labeled RNA was 














































RNA 19 5’P-AUAUGCAUAAAGACCAGGC -3’ 
RNA 22 5’P-UAUAUAUGCAUAAAGACCAGGC -3’ 
RNA 24 5’P-CAUAUAUAUGCAUAAAGACCAGGC -3’ 


















2.4. ATPase activity assay 
ATPase activity assay was performed as previously described (56). Each 20 µl 
reaction contains 0.66 pmol of [γ-32P] ATP, 6 pmol of nucleases, 5.6 pmol of DNA or 
RNA and 0.2 mM of MgCl2. The reaction mixture was incubated for 45 min at 37ºC 
and terminated by addition of EDTA to 0.5 mM and cold ATP to 0.6 mM. About 2 µl 
from each reaction was spotted onto TLC PEI plate (Merck) and developed in 0.6 M 
KH2PO4 (pH 3.4). The extent of ATP hydrolysis was detected by phosphorimager. 
 
2.5. Helicase assay 
RNA/DNA duplex helicase assay was performed as previously described(57). The 
substrate for the assay consisted of an RNA/DNA duplex formed by 5’ radiolabeled 
65bp of DNA oligonucleotide annealed to 3’ end of 31bp of RNA. The 
oligonucleotides are purchased from IDT. The RNA/DNA duplex was incubated with 
the desired enzyme at a molar ration of 1:30 (duplex:protein) in a reaction buffer used 
in in-vitro transcription termination assay. Aliquots were taken at each time point and 
mixed with 1 volume of stop/loading buffer containing 50 mM EDTA, 1% SDS, 0.1% 
xylene cyanol, 0.1% bromophenol blue and 20% glycerol. Samples were separated by 
electrophoresis on 11% native PAGE gel.  
 
2.6. Western blotting analysis 
Western blotting analysis is performed as described somewhere else. Purified 
polymerase fractions were boiled at 95’C with 1X SDS buffer for 10 min and 
separated by electrophoresis on 12% PAGE gel. α-Ser2P antibody and α-Rpb3 










3.1. in-vitro transcription termination assay 
To unravel the mechanism of RNAPII termination, I adopted in vitro transcription 
termination assay that was previously developed by Cramer and colleagues (Fig 3.1) 
(28). This simplified system mimics an elongation complex (EC), consisting of 
double stranded DNA, 31 nt 5’-phosphorylated RNA and purified RNAPII. The ECs 
were immobilized to streptavidin-coated magnetic beads by the use of biotin at the 
5’-end of the non-template DNA strand. The 3’-end of RNA was labeled via [α-32P] 
UTP incorporation by RNAPII. After washing out unincorporated [α-32P] UTP, 
Rat1/Rai1 was added with or without other factors to EC, and RNAPII termination 
was monitored. In this set-up, Rat1/Rai1 would initially degrade RNA up to the 
surface of RNAPII (~17/18nt). Once being hit by Rat1/Rai1, if RNAPII is 
terminated, the RNA would be no longer protected by the polymerase and degraded 
by Rat1. In contrast, if RNAPII is not terminated, the template bound polymerase 
would continue to elongate in the presence of NTPs, generating ~54/55 nt run-off 
transcript (Fig 3.1). 
 
3.2. Purification of RNAPII and Rat1/Rai1 recombinant proteins 
To perform the in-vitro transcription termination assays, RNAPII and Rat1/Rai1 were 
expressed and highly purified from Saccharomyces cerevisiae and Escherichia coli, 
respectively (Figure 3.2). The detailed procedure is described in materials and 
methods section.  
 
3.3. Rat1/Rai1 terminates efficiently RNAPII in the presence of ATP in-vitro 
When Rat1/Rai1 was added to ECs, the vast majority of RNAs were degraded up to 
~17/18 nt but subsequently extended to ~54/55 nt by RNAPII. RNA signals from the 
Rat1/Rai1-treated ECs were about 60% of the control lacking nuclease (no nuclease 




inefficiently as previously reported (28) (Fig 3.3.a and b, left panel) However, I 
surprisingly found that the remaining RNA level was dramatically decreased by 
Rat1/Rai1 upon adding ATP (2 mM) (Fig 3.3.a and b, right panel), indicating that 
ATP significantly enhances Rat1/Rai1-mediated RNAPII termination. Titration 
experiments obviously detected the improved termination at as low as 0.5 mM ATP 
(Fig 3.4). This ATP-dependent effect seems specific to Rat1/Rai1 only because no 
nuclease control or RNase I do not lead to similar decrease in the RNA level after 
ATP treatment (Fig 3.3.c).  
 
3.4. Rat1/Rai1 does not have an ATPase activity 
I first postulated that ATP-dependent RNAPII termination might occur via ATP 
hydrolysis by Rat1/Rai1. Since 5’-pyrophosphohydrolase activity of Rai1 is limited 
only to RNA substrates (21), I tested whether Rat1 may possess an ATP hydrolyzing 
activity. But several fractions of highly-purified Rat1/Rai1 from size-exclusion 
chromatography (Superose 6) did not show ATPase activity (Fig. 3.5.a). Similarly, 
Xrn1 does not have ATPase activity either (Fig 3.5.a), as predicted from amino acids 
sequences of XRN family proteins. However, when non-hydrolyzing ATP analogs 
were used in termination assay, RNAPII termination was significantly reduced, as 
judged by the increase of remaining RNA level (Fig. 3.5.b), indicating that ATP 












Figure 3.1. in-vitro transcription termination assay scheme 
The EC was assembled with double-stranded DNA (EC1), 5’ phosphorylated RNA and 
purified RNAPII, and subsequently coupled to magnetic beads. The 3’-end of RNA is 
radioactively labeled by RNAPII. Rat1/Rai1 digests RNA from 5’ to 3’ direction up to the 
surface of RNAPII. If Rat1/Rai1 fails to terminate RNAPII, the polymerase would elongate 
further using NTPs. But if Rat1/Rai1 terminates RNAPII, the remaining RNA protected by 
RNAPII would be completely degraded by Rat1/Rai1. Red arrow specifies the position (n) of 














Figure 3.2. Purification of RNAPII and Rat1/Rai1 recombinant proteins 




















Figure 3.3. Termination of RNAPII by Rat1/Rai1 in the presence of ATP in-vitro 
(a) Representative gel images of in vitro transcription termination assay with Rat1/Rai1 
treatment. Rat1/Rai1 does not terminate RNAPII by itself but it can in the presence of ATP. 
Black arrows indicate RNAs predicted in (Fig 3.1). Red arrows show ATP-misincorporated 
RNAs. D, digestion by Rat1/Rai1. E, Extension of RNA after addition of NTPs mix. (b) 
Quantification of the remaining RNAs compared to the control lacking nuclease (set to 
100%). (c) Quantification of the remaining RNAs after ATP treatment compared to no ATP 









Figure 3.4. ATP titration assay shows minimal concentration of ATP for ATP-dependent 
Rat1-mediated RNAPII termination 
ATP-dependent Rat1-mediated RNAPII termination occurs when the concentration of ATP 















Figure 3.5. Rat1/Rai1 does not have an ATPase activity. ATP hydrolysis is still important for RNAPII 
termination. 
(a) ATPase activity assay of Rat1/Rai1. Calf intestinal phosphatase (CIP), SV40 T antigen (T 
ag) and Xrn1 were used for controls. Highly purified Rat1/Rai1 fractions from size-exclusion 
chromatography (Superose 6) show no ATPase activity. (b) Quantification of the remaining 









3.5. NTP misincorporation induces RNAPII pausing and enhances termination 
efficiency by Rat1/Rai1 
Intriguingly, I saw additional RNA band when ATP was added in the assay: ~34 nt in 
case of no nuclease control, and ~20/21 nt in RNase I-treated group (Fig 3.3.a, right 
panel). These RNAs seem to be generated by ATP misincorporation via template 
misalignment (39,40), since ATP is complementary to thymine at n+1 and n+2 
positions of the template DNA strand (Figure 3.1). When ATP misincorporates into 
RNA transcripts, I observed that elongation of RNAPII was significantly blocked (Fig 
3.3.a), presumably due to disruption and/or rearrangement of RNAPII active center 
(52,58). I hypothesized that RNAPII with disrupted active center might be more 
effectively terminated by Rat1/Rai1.  
To investigate whether NTP misincorporation could induce RNAPII pausing and 
enhance subsequent termination by Rat1/Rai1, other NTPs were separately added to 
RNAPII assembled in the same EC1 scaffold (Fig 3.6). In fact, non-cognate GTP 
addition also resulted in longer (~34/35 nt) RNA transcripts via template 
misalignment and lesser RNAPII elongation (Fig 3.6. left gel image). When GTP was 
co-treated with Rat1/Rai1, it caused RNAPII termination as efficiently as ATP (Fig 
3.6. right quantification graph). Another non-cognate UTP produced ~32 nt RNA 
transcripts and strongly blocked RNAPII elongation, probably because UTP 
misincorporation results in a UU pause sequence at RNA 3’-end that is shown to adopt 
a frayed position in the pore below the active center (58). Upon adding with Rat1/Rai1, 
UTP induced RNAPII termination, albeit it was far less efficient than ATP (Fig 3.6). 
However, the cognate CTP did not significantly cause RNAPII pausing nor 
termination, compared to non-cognate ATP and GTP (Fig 3.6).  
To further verify this NTP misincorporation effect, a different DNA sequence 
template (EC2 scaffold) was tested in the in-vitro system (Fig 3.7). Again, non-




efficiently than cognate GTP does (Fig 3.7), confirming that NTP misincorporation 
indeed affects RNAPII termination by Rat1/Rai1. Although the incoming UTP is non-
cognate to both EC scaffolds tested and generates a mismatching UU sequence, its 
effect on RNAPII pausing and termination by Rat1/Rai1 significantly varies at each 
EC scaffold (Fig 3.7), suggesting that sequence context may also affect the 














Figure 3.6. NTP misincorporation induces RNAPII pausing and enhances termination 
efficiency by Rat1/Rai1. EC1 is tested. 
DNA sequences are shown on top of the quantification graph. Asterisk specifies the 
incorporation site of an incoming NTP (n position).  EC1 Scaffold tested. In a control group 
lacking nuclease, addition of non-cognate ATP or GTP generates misincorporated RNA 
bands via template misalignment (blue arrows, ~34/35 nt) whereas cognate CTP does not. 
Notably, Rat1/Rai1 more efficiently terminates RNAPII when non-cognate NTP (ATP or 
GTP) rather than cognate CTP was added. Addition of UTP to EC1 induces strong pausing of 
RNAPII that does not support further elongation (red arrow), which results in slight 













Figure 3.7. NTP misincorporation induces RNAPII pausing and enhances termination 
efficiency by Rat1/Rai1. EC2 is tested.  
EC2 scaffold tested. Different sequences are shown in red. Rat1/Rai1 more effectively 

















3.6. Other yeast 5’-3’ exoribonucleases can terminate RNAPII efficiently at least 
in-vitro. Rat1/Rai1 cannot terminate E. coli RNAP in-vitro.  
Since the human homologue of Rat1, hXrn2, also plays a key role in RNAPII 
termination (14,59), I examined whether NTP-misincorporation could enhance 
termination by hXrn2. Indeed, hXrn2 better terminated RNAPII in the presence of 
ATP (Fig 3.8.a), demonstrating that this mechanism is conserved between yeast and 
human. In fact, paused RNAPII over the G-rich region of human β-actin gene was 
shown to be efficiently terminated by hXrn2 along with Senataxin (60). 
We also tested a cytoplasmic 5’-3’ exoribonuclease, Xrn1. In contrast to Rat1, 
Xrn1 terminates RNAPII very effectively even without ATP (Fig 3.8.b). It is 
surprising because nuclear-localized Xrn1 was previously shown to be incapable of 
rescuing the termination defect in rat1-1 mutant (61). But my assay shows that 
degradation of RNA by 5’-3’ exonuclease activity of Xrn1 is sufficient to terminate 
RNAPII at least in vitro. It implies that Xrn1 may have a higher processivity than Rat1 
which would be useful to translocate proteins ahead of it (e.g. RNAPII). Supporting 
this hypothesis, Xrn1 was shown to processively degrade RNA substrates containing 
stem-loop structure (62,63) and employ an unwinding mechanism via substrate 
translocation past a steric barrier that excludes double-stranded regions (64). Based 
on this, I tested if Rat1 has any helicase activity, thereby leading to termination or not, 
and turns out Rat1/Rai1 does not show helicase activity as expected (Fig 3.9).  
The reason why nuclear-localized Xrn1 fails to terminate RNAPII in vivo would 
be probably because it cannot make the same interaction as Rat1 with RNAPII and/or 
other key factors necessary for termination. 
To investigate whether Rat1 can terminate other polymerases, E. coli RNAP was 
tested. Although Rat1/Rai1 successfully reached E. coli RNAP by degrading RNA, it 
was not able to terminate the polymerase. As previously reported (39), NTP 
misincorporation occurred in the bacterial RNAP as similarly as the yeast RNAPII, 




But it did not significantly enhance the termination of E. coli RNAP by Rat1/Rai1 
(Fig 3.11). This result suggests that specific protein-protein interaction(s) between 





















Figure 3.8. Other 5’-3’ exoribonuclease also terminates RNAPII at least in vitro. 
(a) hXrn2 terminates yeast RNAPII more efficiently in the presence of ATP. Quantification 
of the remaining RNAs was shown below. (b) Yeast Xrn1, Rat1’s cytoplasmic counterpart, 
terminates RNAPII regardless of ATP in vitro.  Quantification of the remaining RNAs was 














Figure 3.9. Rat1/Rai1 does not have helicase activity 
Rat1/Rai1 cannot unwind single-stranded DNA/RNA hybrid. Strand scheme is shown up on 
the top right corner. 31bp of single strand RNA is annealed to 65bp of single-strand DNA, 
resulting 20bp of DNA/RNA hybrid. Assay was done in the presence or absence of 1mM of 
ATP. A known ATP-dependent helicase SV40 T antigen is used for a control. Enzymes are 
incubated with DNA/RNA hybrid for up to 40 minutes and the reaction was stopped at 
















Figure 3.10. Rat1/Rai1 cannot terminate E.coli RNAP even though the polymerase is 
paused due to NTP misincorporation 
(a) E.coli RNAP is treated with 1mM of each NTP for 30 min, and shows NTP 
misincorporation pattern same as observed in yeast RNAPII experiment (b) Although E.coli 
RNAP shows similar pattern of NTP misincorporation as yeast RNAPII does, Rat1/Rai1 
cannot terminate E.coli RNAP in vitro, and addition of each NTP had no effect either, which 




3.7. The length of RNA degraded by Rat1 affects RNAPII termination 
To analyze whether the length of RNA within EC might affect loading of Rat1/Rai1 
and subsequent RNAPII termination, we tested ECs having variable lengths of RNA 
(20, 23, 25, 31 and 41 nt). The 20 nt RNA was readily degraded by Rat1/Rai1 up to 
~17/18 nt, indicating that extra 2 or 3 nt would be sufficient to be recognized by 
Rat1/Rai1 (Fig 3.11). 
 Surprisingly, I found that termination efficiency increases as the RNA within EC 
gets longer (Fig 3.11). In the presence of ATP, the remaining RNA level after 
Rat1/Rai1 treatment drastically decreases from 74.6% (20 nt RNA) to 26.9% (41 nt 
RNA) (Fig 3.11.a and b). But in a control group lacking nuclease, the remaining RNA 
level did not significantly altered after ATP addition (Fig 3.11.c). I also observed this 
RNA length effect even in the absence of ATP after Rat1/Rai1 treatment [from 68.7% 
(20 nt) to 46.7% (41 nt)], although little weaker than in the presence of ATP (Fig 
3.12.b). These results indicate that RNA degradation step is critical for Rat1/Rai1 to 
trigger RNAPII termination. One plausible explanation would be that, while 
degrading RNAs, Rat1/Rai1 might accumulate a driving force to mechanically 
dissociate RNAPII from the template. 
To determine which protein induces the RNA length effect observed, the same 
experiment was performed without Rai1. Similarly to Rat1/Rai1, Rat1 terminates 
RNAPII more effectively as it degrades longer RNA (Fig 3.12), implying that the 
RNA length effect derives from Rat1. But compared to Rat1/Rai1 (Fig 3.11.b), Rat1 
alone terminates RNAPII more efficiently (Fig 3.12.b), and reached the highest level 
of termination (~25%) at 41 nt RNA, regardless of ATP addition (Fig 3.12.a). 
Consistently, hXrn2 also terminates RNAPII better than Rat1/Rai1 (Fig 3.8.a). These 
results implies that Rai1 may act negatively on or fine-tune the ‘RNAPII-dislodging’ 
function of Rat1 at the final step, although it helps Rat1 to degrade structured RNAs 








Figure 3.11. The length of RNA degraded by Rat1/Rai1 affects RNAPII termination.  
Five ECs harboring different lengths of RNA were tested in the assay. (a) Representative gel 
images of Rat1/Rai1-treated in vitro transcription termination assay. (b) Quantification 
graph of the remaining RNAs after Rat1/Rai1 treatment without or with ATP addition. The 
remaining RNA amounts without or with ATP addition in no nuclease (NN) groups (a or b, 
respectively; blue box in gel images) were set to 100% at each EC, and the percentage of 
remaining RNA amounts in Rat1/Rai1-treated groups without or with ATP treatment (c/a 
or d/b, respectively) were calculated for each EC. In the presence of ATP, the remaining 
RNA level after Rat1/Rai1 treatment rapidly decreases as the RNA gets longer. But it 
moderately decreases in the absence of ATP. (C) Quantification of the remaining RNAs 
after ATP addition in no nuclease (NN) or Rat1/Rai1-treated groups. The remaining RNA 
amounts without ATP addition (a or c, respectively) were set to 100%, and the percentage 
of remaining RNA amounts after ATP addition (b/a or d/c, respectively) were calculated for 
each EC. The remaining RNA amounts specifically and gradually decreases by Rat1/Rai1 as 








Figure 3.12. RNA length effect to termination is derived from Rat1 
(a) Quantification graph of the remaining RNA amounts without or with ATP addition after 
Rat1 treatment. It shows dramatic decrease in the remaining RNA level as the RNA length 
increases, but there is little difference in the remaining RNA levels, regardless of ATP 
addition, at the ECs harboring 31 nt and 41 nt RNAs. (b) Rat1 terminates RNAPII as similarly 











3.8. 5’-3’ exoribonuclease activity of Rat1 is essential for RNAPII termination 
To validate the role of 5’-3’ exoribonuclease activity in termination, I generated a 
catalytically inactive (exo-) form of Rat1 by mutagenizing three conserved acidic 
residues in the active site (E203A, D233A, and D235A). This rat1 mutant (referred to 
as rat1EDD) was co-expressed and purified as a complex with Rai1 in E. coli cells. 
Since rat1 EDD does not have 5’-3’ exoribonuclease activity, the elongation 
efficiency (run-off RNAs to initial starting RNAs) rather than the remaining RNA 
level was measured to determine the extent of RNAPII termination. rat1EDD/Rai1 
did not degrade RNAs nor decrease RNAPII elongation (Fig 3.13), confirming that 
RNA degradation by exonuclease activity is critical to RNAPII termination.  
A recent study claimed that Rtt103 allowed exonucleolytic-deficient Rat1 (D235A) 
to access and terminate RNAPII, suggesting that exonucleolytic activity of Rat1 may 
not be a key feature that triggers termination (25). However, I did not observe a rescue 
of termination defect of rat1EDD by adding Rtt103 in the assay (Fig 3.14). 
Consistently, the lethality of rat1EDD mutation was not suppressed by introducing 
a multi-copy plasmid of Rtt103 gene (Fig 3.15). Furthermore, gel filtration profiles 
show that only a small portion of rat1EDD/Rai1 is bound to Rtt103, whereas the 
majority of wild-type Rat1/Rai1 is complexed with Rtt103 (Fig 3.15). It indicates that 
rat1EDD significantly lost the binding affinity for Rtt103, arguing against the role of 
Rtt103 in bridging exo- rat1 to RNAPII CTD to complement the defective 
exonuclease activity. The discrepancy could be partially due to additional mutations 
in the Rat1 active site (D235A vs. E203A, D233A, D235A), but not likely due to the 
lack of RNAPII CTD Serine 2 phosphorylation in our assay system, since I detected 
significant levels of CTD phosphorylation at Serine 2 (Fig 3.17). Taken together, my 
results clearly show that the exoribonuclease activity is required for Rat1 not only to 
approach RNAPII but also to get a sufficient driving force to dislodge the polymerase 





Figure 3.13. Exonucleolytic-deficient mutant rat1EDD/Rai1 cannot terminate RNAPII, and 
Rtt103 cannot rescue the termination defect of rat1EDD/Rai1 
(Left) Representative gel image.  rat1EDD/Rai1, regardless of Rtt103 addition, does not 
terminate RNAPII. (Right) Quantification of the extended run-off RNA amounts relative to 
the initial starting RNAs without or with ATP addition. rat1EDD does not reduce the RNA 













Figure 3.14. Exoribonuclease function is essential for cell viability and Rtt103 cannot 
restore the lethality of rat1EDD mutant 
 Multiple copies of Rtt103 gene cannot rescue the lethality of rat1EDD mutation. pRS415-
Rtt103 produces single copy of Rtt103 and pRS425-Rtt103 does multiple copies of Rtt103. 




















Figure 3.15. Exonucleolytic-deficient rat1EDD/Rai1 shows reduced interaction with 
Rtt103 relative to Rat1/Rai1. 
(a) Coomassie stained gel images of highly purified Superpose 6 fractions (b) Elution 
profiles of size-exclusion chromatography (Superose 6) of Rat1/Rai1/Rtt103 (RRR) and 
rat1EDD/Rai1/Rtt103 (rRR) show that most of Rat1/Rai1 is co-eluted with Rtt103, whereas 
most of rat1EDD/Rai1 is not. It indicates that rat1EDD shows reduced binding with Rtt103, 
compared to wild-type Rat1. The peak (height x elution volume) for RRR (blue) is 1st:2nd 








Figure 3.16. Ser2 phosphorylation level of RNAPII is detected by western blot  
The phosphorylation level of highly purified RNAPII is detected by western blot. Ser2-
phosphorylated Rpb1 (192 kDa) and Rpb3 (35 kDa) were detected by monoclonal α-Ser2P 
















In this work, I discovered novel mechanistic features of RNAPII termination by 
Rat1/Rai1 using in vitro system (Fig 4.1). Firstly, Rat1/Rai1 more efficiently 
terminates RNAPII when NTP misincorporates and induces pausing of the 
polymerase. Secondly, Rat1/Rai1 may need to make direct interaction with target 
RNAPs to trigger termination since it is unable to terminate E. coli RNAP, presumably 
due to lack of specific contacts with subunits of bacterial RNAPs. Lastly, the length 
of RNA degraded is positively correlated with the efficiency of termination. Thus, 
degradation of RNA by 5’-3’ exoribonuclease activity is not only crucial for Rat1 to 
gain access to RNAPII, but it may be also important to build up a driving force to 
dissociate the polymerase. 
NTP misincorporation impairs RNA extension in several ways. These include 
disruption of RNAP active site conformation and generation of an offline state of the 
EC with a frayed RNA 3’-end (52). Paused RNAPII in these states may have subtle 
changes in the structure near the RNA exit channel and/or in the stability of the DNA-
RNA hybrid that can be more easily accessed by Rat1/Rai1. Mismatches often 
facilitate RNAP backtracking and RNA cleavage, which rescues the paused 
polymerase to elongate. TFIIS stimulates a weak intrinsic cleavage activity of 
RNAPII (53), and helps to maintain transcriptional fidelity during transcription (46). 
However, TFIIS occupancy greatly reduces at 3’-untranslated region of genes (65), 
indicating that RNAPII approaching the termination sites might not have TFIIS within 
the complex. It may contribute, at least in part, to the occurrence of mismatches near 
the termination sites that make RNAPII more vulnerable to Rat1/Rai1. 
Although non-cognate NTPs stimulate Rat1-mediated termination, termination 
efficiencies affected by each non-cognate NTP were not the same (Figure 3). It is 
presumably because the extent of misincorporation and mismatch extension 
apparently differs at each mismatch pair, as demonstrated previously (52). It is also 




resulted in 20-30% better termination than pre-treatment of non-cognate NTPs to ECs 
before Rat1/Rat1 addition (data not shown), suggesting that NTPs play an extra role 
in Rat1-mediated termination besides misincorporation. Co-existing NTPs may 
increase a processivity of Rat1 via as yet unknown allosteric mechanism. 
Alternatively, it may activate a cryptic RNase H activity to degrade RNAs within the 
DNA-RNA hybrid, leading to dissociation of the polymerase as previously 
hypothesized (28,66).  
The bacterial RNAP from E. coli was not terminated by Rat1/Rai1 regardless of 
that pausing phenomenon occurs due to the NTP misincorporations. This result can 
suggest that direct contact between Rat1/Rai1 and the polymerase at the final step of 
termination would be specific to dislodge the polymerase. Supporting this idea, 
another RNAPII termination factor, Sen1 was not able to terminate E. coli RNAP, 
either (67). These results indicate that both Rat1 and Sen1 could recognize unique 
features of eukaryotic RNAPII despite the structural similarities between eukaryotic 
and bacterial polymerases. I would suggest that Rat1 may interact with RNAPII near 
the RNA exit channel and/or the CTD, but for the precise prediction of interfacing 
region between Rat1/Rai1 and RNAPII, further structural studies will be required.   
Termination efficiency enhances as the length of RNA degraded by Rat1 increases, 
proposing that multiple rounds of processive RNA hydrolysis would lead to more 
effective termination. We postulate that RNA hydrolysis may allow Rat1 to gradually 
accumulate a driving force to trigger termination, but the underlying mechanism is 
currently not understood. Alternatively but not exclusively, Rat1 may need a minimal 
length of RNA to engage in the termination process. Along the same line, Sen1 was 
recently shown to require at least ~15 nt RNA protruding from RNAPII to elicit 
termination (67), although the reason is not known. Since the highly conserved 
catalytic center of Xrn family proteins accommodates only the 5’-terminal 
trinucleotides (64), the rest of nascent RNA transcript may somehow transiently 




pulling out the nascent transcript from the RNAPII active center. In either scenario, 
the RNA length effect manifests an essential role of exonuclease activity in Rat1-
mediated termination. Notably, the rat1EDD mutant was not able to terminate 
RNAPII even when it was put next to the polymerase using the shortest 20 nt RNA 
(~3 nt protruding from RNAPII, which allows recognition by Rat1) in the assay (data 
not shown). It elucidates that RNA degradation process is probably more important to 
termination than direct interaction between Rat1 and RNAPII, although we cannot 
rule out a possibility that the rat1EDD mutant fails to induce anticipated 
conformational changes of RNAPII as well when contacted the polymerase.  
It would be interesting to see how multiple mechanistic features differentially 
contribute to RNAPII termination at individual genes. For genes whose transcription 
termination sites (TTS) are relatively far from p(A) sites, degradation of the 
downstream RNA transcript and subsequent specific RNAPII interaction by Rat1 
would be sufficient to trigger termination. However, if p(A) sites and TTS are in close 
proximity, pausing of RNAPII by either NTP misincorporation or specific pausing 
sequences might help Rat1 to displace the polymerase. But needless to say, all these 
















Figure 4.1. Multiple mechanistic features contribute to Rat1-mediated RNAPII 
termination 
Disruption of the RNAPII active center due to NTP misincorporation or specific sequences 
facilitates termination by Rat1/Rai1 in vitro. Specific interaction between Rat1/Rai1 and 
RNAPII is shown to be critical, since Rat1/Rai1 cannot terminate E. coli RNAP. Furthermore, 
Rat1 needs to degrade RNA transcripts to build up a driving force for termination. Thus, 5’-
3’ exonuclease activity is essential for Rat1 not only to gain access to RNAPII, but also to 
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6. Abstract in Korean 
5´-3´ exoribonuclease Rat1 에 의한 RNA 
중합효소 II 의 전사 종결 기작의 특징 규명 
 
박지은 




5´-3´ exoribonuclease 인 Rat1 은 coding gene 을 위한 RNA 중합효소 II 의 전사 
종결을 촉진하는 것으로 알려져 있지만 그 자세한 분자 생물학적 기작은 아직 알려져 
있지 않다. 본 연구는  in-vitro 시스템을 이용하여 전사중 NTP misincorporation 이 
일어났을 때, RNA 중합효소 II 의 active site 가 망가지고 이로 인해 Rat1/Rai1 이 더 
효과적으로 전사 종결을 일으킨다는 것을 밝혀내었다. 흥미롭게도 Rat1/Rai1 은 같은 
현상이 E.coli RNAP 에 일어났을 때는 전사 종결을 시키지 못함으로 인하여 단백질간 
특이 결합이 전사 종결에 있어 중요한 역할을 한다는 것을 발견하였다.  또한, Rat1 에 
의한 전사 종결 효율이 Rat1 이 분해하는 RNA 의 길이가 길어짐에 따라 증가하는 것을 
확인하였다. 이는 Rat1 이 RNA 를 분해 하는 과정에서 RNAPII 를 DNA template 




것이라는 점을 의미한다. 본 연구는 위와 같은 발견들을 통하여 Rat1 을 매개로 한 
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